WHO-GMP, CDSCO and the paper trail that gets your container cleared, not quarantined.

Pharmaceutical exports are a paperwork business. The medicine is the easy part. The binder that travels with it — ten to fifteen documents per shipment, every document cross-referenced — is where the expertise lives, and where first-time importers burn the first fortnight of a new supplier relationship.

This post walks the full Indian pharmaceutical export documentation chain, in the order the papers are issued, and explains what each one does and why it matters. It is written for procurement leads and hospital pharmacy heads who want to know what a complete file looks like before the container leaves Nhava Sheva.

Why documentation is 80% of the conversation

There is a pattern in every first-time pharmaceutical import into a new market. The commercial discussion — price, lead time, minimum order quantity — takes two emails. The regulatory discussion takes two weeks. And of that two weeks, approximately three days are spent on actual regulatory substance, and the rest on finding, formatting, attesting, legalising or re-issuing a document that should have been there on day one.

The reason is simple: every destination authority has its own list, and the overlap across the GCC, Africa and the UK is about 70%. The remaining 30% is what kills first-time shipments. A supplier that has done the lane before has already absorbed that 30% into a standing checklist. A supplier that has not, will learn it at your expense.

WHO-GMP: what the certificate actually says

The WHO-GMP certificate is the baseline quality credential for international pharmaceutical trade. Issued in India by the State Licensing Authority of the state where the manufacturing site sits, and referenced upstream by CDSCO, a WHO-GMP certificate certifies that a named manufacturing site complies with the WHO Good Manufacturing Practice guidelines for pharmaceuticals.

What it says, in plain language:

• This factory is inspected, and inspected regularly.
• The systems for raw-material control, production, QC and batch release meet a named international standard.
• The facility is authorised to manufacture the dosage forms listed on the certificate.

What it does not say: anything about the specific batch you are about to import. That is the Certificate of Analysis's job, further down the chain.

CDSCO, CoPP and the Indian regulatory core

The Central Drugs Standard Control Organisation (CDSCO) is India's apex drug regulator. For exports, the two CDSCO-linked documents that matter most are the Certificate of Pharmaceutical Product (CoPP) and the Free Sale Certificate (FSC).

Certificate of Pharmaceutical Product (CoPP)

Issued in WHO-recommended format, usually by CDSCO or by the state authority with CDSCO countersignature, a CoPP certifies four things about a specific product:

1. The product is authorised for marketing in India (or, for export-only products, is manufactured under a loan-licence or equivalent arrangement that permits its export).
2. The manufacturing site is GMP-compliant.
3. The product's formulation, pack size, shelf life and label are as specified.
4. The authorising country (India) has no reason to object to its sale in the importing country.

Every GCC authority and most African health regulators require a CoPP for initial product registration and for named-patient imports. It is typically valid for two years from issue.

Free Sale Certificate (FSC)

The FSC is the shorter cousin of the CoPP — a letter confirming the product is freely sold (or freely exportable) from the issuing country. Some authorities will accept an FSC where a CoPP is not strictly required; others will insist on the CoPP. The rule of thumb: if the destination authority is ambiguous, issue both.

The full documentation chain, in order

For a typical pharmaceutical export shipment from India into a regulated market, the documents travel in roughly this sequence:

1. WHO-GMP certificate of the manufacturing site (long-lived, reissued periodically).
2. Product dossier — CTD or eCTD format for regulated markets, simplified for others — submitted to the destination authority for product registration. This is a one-time exercise per product per market, but it sits upstream of everything else.
3. Destination-country Marketing Authorisation (or named-patient permit, for unlicensed imports).
4. Purchase order from the importer, with quantity, pack and destination.
5. CDSCO CoPP — product-and-site-specific, dated.
6. Free Sale Certificate (where required).
7. Certificate of Analysis (CoA) — batch-specific, issued by the manufacturer's QC lab.
8. Certificate of Origin — issued by an accredited chamber of commerce in India (or FIEO).
9. Commercial invoice and packing list — matched to the import permit quantity.
10. Destination-market pack insert and artwork — with authority-required translations.
11. Bill of Lading / Air Waybill — with shipper and consignee details matching the permit.
12. Cold-chain logger data — for 2–8°C and −20°C shipments, provided at destination before release.
13. Insurance certificate — cargo insurance, with the applicable excursion clause for cold-chain.

That is a minimum file for a standard shipment. Controlled drugs, biologicals, narcotics and radiopharmaceuticals add additional layers. Tenders add the bid-specific documentation package.

The four missing papers that stall 80% of first-time shipments

Every supplier that has done this for more than a few years has an internal list of the papers that are almost always missing when a new importer sends the first draft of a shipment file. In our experience, these four are the big ones:

1. Batch-specific CoA, not generic product CoA. The generic product CoA is for the product's typical specifications. The destination authority wants the specific lot's QC data. These are not the same document, and a generic CoA will get a file bounced.
2. CoPP dated within the validity window. A CoPP from two years and one week ago will stop the shipment. Refresh early.
3. Certificate of Origin from an accredited chamber. Not a simple origin declaration on letterhead. The destination authority wants the stamp of a chamber of commerce or FIEO — and some authorities want it attested at the embassy on top.
4. Pack insert translation with the correct regulatory content. An Arabic translation that reads correctly is not automatically the authority-approved insert. Some markets require the exact phraseology the authority has used in its approved artwork.

Destination-country variations

United Arab Emirates — MOHAP / DHA / DoH

MOHAP is the federal licensing authority and handles product registration. DHA and DoH overlay emirate-level pharmacy licensing. For cross-border product approvals, the GCC Centralized Registration route can short-cut MOHAP specifically.

Saudi Arabia — SFDA

SFDA runs the most documentation-heavy registration and import regime in the GCC. The SFDA e-portal is non-optional. Arabic is the working regulatory language.

Nigeria — NAFDAC

Product registration is a precondition for commercial imports. Named-patient exceptions exist but require the separate import-permit letter. Physical inspection at port is standard.

United Kingdom — MHRA

For Marketing Authorisation holders, the MHRA's full dossier regime applies. For named-patient and specials imports, the MHRA's Specials Licence regime is the route — with a noticeably different documentation footprint from the GCC equivalents.

FAQ

Is WHO-GMP the same as EU-GMP?

No. WHO-GMP and EU-GMP are related but distinct standards. EU-GMP is typically stricter, particularly around sterile manufacturing, and is required for products sold in the EU and EEA. WHO-GMP is the baseline for most GCC, African and South-East Asian imports. Many Indian manufacturing sites hold both certifications.

How long is a CoPP valid?

Typically two years from date of issue, though the destination authority's acceptance window may be shorter. Always check the destination authority's current guidance — some GCC regulators have reduced the accepted window to one year.

Who issues the Certificate of Origin for Indian pharmaceutical exports?

An accredited chamber of commerce in India, or the Federation of Indian Export Organisations (FIEO), issues the Certificate of Origin. Some destination authorities additionally require embassy attestation.

Does M Care handle the full documentation chain?

Yes. We run an in-house regulatory desk in Mumbai that handles WHO-GMP, CDSCO CoPP and FSC procurement, batch CoA matching, Certificate of Origin issuance, destination-country import permits, pack-insert translation and artwork localisation. The binder travels complete, on day one.